ArticleCancer medicine2023

Primary resistance to nivolumab plus ipilimumab therapy in patients with metastatic renal cell carcinoma.

Kazuyuki Numakura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.